 OMA education director receives Distinguished Leadership Award from ACEhp
Dana Mansell, CHCP, works tirelessly as OMA's education director to plan our educational programming. She also serves as the medical specialty society section education committee chair for the Alliance for Continuing Education in the Health Professions (ACEhp). Because of her dedication to planning excellent continuing education programs and leading others to do the same, ACEhp recognizes Dana with this year's Distinguished Leadership Award. This award is presented to someone who's demonstrated significant leadership contributions, resulting in extraordinary forward movements of ACEhp and advancing the profession of continuing education in the health care system. Congratulations, Dana! |
 Earn rewards by referring your colleagues to Obesity Medicine Basics
Obesity Medicine Basics is an introductory course to obesity medicine, appropriate for those who have never heard of obesity medicine or who are new to the field and who want to learn more about evaluating and treating patients with obesity. OMA is offering a new rewards program for members who refer someone to attend Obesity Medicine Basics in 2016. For every person you refer who attends the course and lists you as their referring member, you will earn a $50 Amazon gift card. Courses start in January, so the sooner you start referring, the sooner you'll earn rewards! |
Join us in spectacular San Francisco
This spring, head west for Obesity Medicine 2016, our highly anticipated spring conference. Not only are we offering top-rated education about the latest topics in the field of obesity medicine, but we're staying in one of the most stunning cities on the west coast! The conference takes place at the Hyatt Regency San Francisco, which is minutes away from the waterfront, Financial District, Chinatown, Fisherman's Wharf, Union Square, and more. When you're not learning from the experts about the best practices in obesity medicine and networking with your colleagues, take time to explore San Francisco. |
Call for speakers: Help OAC present the best education for patients at Your Weight Matters Convention
The Obesity Action Coalition (OAC) is holding an open call for speakers now until Jan. 8. OAC's annual conference, the Your Weight Matters National Convention, takes place in Washington, D.C., in August, but planning has already begun. This is an excellent opportunity to submit your speaker and topic ideas for an entirely patient-focused conference and help raise awareness among patients about clinical obesity treatment. Submit your ideas online now through Jan. 8. |
 |
Effects on weight loss in adults of replacing diet beverages with water during a hypo-energetic diet: A randomized, 24-week clinical trial
Madid, A., et al. AJCN, 2015.
Consuming diet beverages is a strategy that many people employ as a way to lose weight. The effect of non-caloric diet beverages compared to water was recently examined in the context of a weight-loss program. Eighty-nine women with obesity who normally consumed diet beverages were asked to either substitute water in place of their diet beverages or continue to drink diet beverages after lunch five times per week for 24 weeks while on a weight-loss program. The study found that after the intervention, the water group had a significantly greater decrease in weight, fasting insulin, insulin-resistance measure, and 2-h postprandial glucose compared to the diet-beverage group. These findings suggest that replacing diet drinks with water may be helpful for women undergoing a weight-loss program. View article
|
Low levels of physical activity are associated with dysregulation of energy intake and fat mass gain over one year
Shock, R. P., et al. AJCN, 2015.
Engaging in low levels of exercise may lead to the inability to accurately perceive energy intake, ultimately resulting in a chronic mismatch of energy expenditure and intake and eventually, obesity. An in-depth study was conducted to examine the association among energy intake, physical activity, appetite, and weight gain in 421 adults during a one-year follow-up period. The study found that low levels of physical activity put adults at risk for fat mass gain over the one-year period. The authors determined that the threshold for individuals to maintain energy balance occurred when individuals took 7,116 steps in a day. This amount of steps per day may be a reasonable suggestion for patients to consider as a way to help regulate their energy intake. View article
|
|
|
*These events are hosted by organizations other than OMA. Contact the organization directly for details.
|
Use the member badge artwork to display your member pride on your website and in your email signature! Log in to get the code.
|
|
Executive Director
Sponsorships and Exhibits Manager
Operations Manager
Education Coordinator
Communication Manager
Executive Director of the Obesity Treatment Foundation
|
|
101 University Blvd.,
Suite 330
Denver, CO 80206
|
|
|
Aleglitazar, a dual-peroxisome proliferator-activated receptor-alpha/gamma agonist, improves insulin sensitivity, glucose control, and lipids in people with type 2 diabetes: Findings from a randomized, double-blind trial
Stirban, A. O., et al. Diabetes, Obesity and Metabolism, 2015.
Peroxisome proliferator-activated receptors (PPARs) are a group of nuclear receptor proteins that regulate the expression of genes specifically involved in carbohydrate, lipid, and protein metabolism, among other functions. Aleglitazar is a dual activator of PPAR-alpha/gamma that has been shown to benefit glucose and lipid profiles. This report of the phase-II trial of aleglitazar examined the potential metabolic benefits of 150 micrograms (ug) aleglitazar daily for 16 weeks in patients with type 2 diabetes on metformin monotherapy compared to placebo. The study showed that aleglitazar significantly improved whole body and hepatic insulin sensitivity compared to placebo without influencing insulin secretion. Aleglitazar also resulted in significant improvements in HBA1c and lipid profiles and was well tolerated. This medication may be a promising future treatment option for individuals with type 2 diabetes who have not had good results with metformin alone. View article
|
|
This spring we're headed to San Francisco for Obesity Medicine 2016, your leading resource for certification exam review and the premiere source of education about managing an obesity medicine clinic, nutrition, and the comprehensive approach to obesity treatment. Build your schedule* to include the courses that most interest you, and earn up to 30 CME/CE. |
Review Course for the ABOM Exam
13.25 CME/CE | April 6-7
Helps prepare those planning to take the American Board of Obesity Medicine (ABOM) certification exam.
| Practice Management Essentials
6.5 CME/CE | April 6
Explains the best business practices for running an obesity medicine clinic, from setting up a practice to boosting patient retention.
|
|
Nutrition Course
6.75 CME/CE | April 7
Outlines the latest evidence-based findings about nutrition and helps you select appropriate nutrition plans for your patients.
| Spring Obesity Summit
17 CME/CE | April 8-10
Addresses topics related to current and emerging research, evidence-based treatment approaches, technologies, and practical methods used by obesity medicine clinicians.
|
|
|
*The Review Course for the ABOM Exam runs concurrently with Practice Management Essentials on Wednesday and the Nutrition Course on Thursday. Registration for the Review Course includes two days of class time, and switching between courses is not allowed.
|
 This one-day course is worth up to 7 CME/CE hours and provides introductory-level training about the evaluation and treatment of patients affected by obesity. Refer a colleague to a course in their area and allow us to introduce them to obesity medicine -- you'll receive a $50 Amazon gift card for every attendee who lists you as their referring member! Learn more about this course. Course dates and cities:- Jan. 16 | Indianapolis
- Jan. 23 | New Orleans
- Jan. 30 | Philadelphia
- Feb. 20 | Raleigh
- Feb. 27 | San Diego
- July 16 | Houston
- July 30 | Minneapolis
- Aug. 13 | Orlando
|
|
|
|
The Obesity Medicine Association and the Obesity Treatment Foundation thank our 2015 Corporate Advisory Council members for their continuous support.
|
© 2015 Obesity Medicine Association. All rights reserved. Materials may not be reproduced, redistributed or translated without written permission. Advertising disclaimer: Under a policy approved by the OMA executive committee and exhibitor/advertiser review committee, commercial companies may apply to advertise in OMA publications. Approval does not imply endorsement or official recognition of particular products or services.
|
|
|
|
